BOWEL NORMALIZER PRODUCT

Brand Owner Address Description
CHRONULAC Merrell Dow Pharmaceuticals Inc. Cincinnati OH BOWEL NORMALIZER PRODUCT;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatroy activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer.